YGD-14234-25454
2 vaccinations
3 coded responses
24 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 436 / OH
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Moderna
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-28
- 2021-02-04
-
2021-02-11
Dose 2 — Moderna
- 2021-02-11
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-02-15
- 2021-02-17
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
-
2021-03-19
Survey response — day 35, dose 2MedDRA: Facial pain, Trigeminal neuralgia, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Severe intermittent facial pain (right side lower jaw area) thought to be trigeminal neuralgia (I assume unrelated to the Covid vaccine but no prior history of these symptoms) · Healthcare visit (other): outpatient appointment scheduledMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-25
- 2021-05-14
-
2021-08-12
Survey response — 6 months, dose 2MedDRA: Trigeminal neuralgia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with trigeminal neuralgiaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-12
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-14
-
2022-02-11
Survey response — 12 months, dose 2MedDRA: Office visit, Trigeminal neuralgia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with trigeminal neuralgia 2- 3 weeks after 2nd Moderna dose; I'm now treated with oxcarbazepine and followed by a neurologist . My symptoms have been remitting and relapsing (currently remitting); I delayed booster due to fears re: relapseMedDRA releases: 2024-11 · check-in free text available
-
2022-02-11
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Moderna | |
| 2 | 2021-02-11 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-19 | Unsuccessful | |
| 2021-08-12 | Unsuccessful | |
| 2022-02-11 | Unsuccessful |
Free text
Release 6 — day 35, dose 2
Symptoms: Severe intermittent facial pain (right side lower jaw area) thought to be trigeminal neuralgia (I assume unrelated to the Covid vaccine but no prior history of these symptoms)
Healthcare visit (other): outpatient appointment scheduled
Release 9 — 6 months, dose 2
Symptoms: Diagnosed with trigeminal neuralgia
Release 11 — 12 months, dose 2
Symptoms: Diagnosed with trigeminal neuralgia 2- 3 weeks after 2nd Moderna dose; I'm now treated with oxcarbazepine and followed by a neurologist . My symptoms have been remitting and relapsing (currently remitting); I delayed booster due to fears re: relapse cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Facial pain | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Trigeminal neuralgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release